SUTENT

Product NDC
0069-0980
11-digit product format
000690980
Labeler code
0069
Product ID
0069-0980_530eef58-b5ab-49f1-8d73-a2dae0356f24
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Sunitinib malate
Dosage form
CAPSULE
Route
ORAL
Labeler
Pfizer Laboratories Div Pfizer Inc
Application
NDA021938
Marketing category
NDA
Marketing start
2006-01-26
Substance
SUNITINIB MALATE
Active strength
50 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021938-001SUTENTSUNITINIB MALATEEQ 12.5MG BASECAPSULE / ORALABRLD2006-01-26
N021938-002SUTENTSUNITINIB MALATEEQ 25MG BASECAPSULE / ORALABRLD2006-01-26
N021938-003SUTENTSUNITINIB MALATEEQ 50MG BASECAPSULE / ORALABRLD, RS2006-01-26
N021938-004SUTENTSUNITINIB MALATEEQ 37.5MG BASECAPSULE / ORALABRLD2009-03-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
N021938-001AB
N021938-002AB
N021938-003AB
N021938-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N021938-001SUTENTEQ 12.5MG BASECAPSULE / ORALABRLD2006-01-26a50c72e98297…
2026-08-01 22:54:322026-06N021938-002SUTENTEQ 25MG BASECAPSULE / ORALABRLD2006-01-26a50c72e98297…
2026-08-01 22:54:322026-06N021938-003SUTENTEQ 50MG BASECAPSULE / ORALABRLD, RS2006-01-26a50c72e98297…
2026-08-01 22:54:322026-06N021938-004SUTENTEQ 37.5MG BASECAPSULE / ORALABRLD2009-03-31a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N021938-001AB1a50c72e98297…
2026-08-01 22:54:322026-06N021938-002AB1a50c72e98297…
2026-08-01 22:54:322026-06N021938-003AB1a50c72e98297…
2026-08-01 22:54:322026-06N021938-004AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SUTENTSUNITINIB MALATEPfizer Laboratories Div Pfizer Inc43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c2026-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021938
application number: NDA021938
ndc (product): 0069-0980

Additional Listing Data#

Finished product
Yes
Brand name base
SUTENT
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SUNITINIB MALATE50 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
LVX8N1UT73Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 8 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
616279Internal RxNorm lookup
616283Internal RxNorm lookup
616285Internal RxNorm lookup
616287Internal RxNorm lookup
616289Internal RxNorm lookup
616292Internal RxNorm lookup
1541890Internal RxNorm lookup
1541928Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9cAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c71c27c5-81ab-f132-824f-21f56518b6f9Product name320250516
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0069-0980-38SUTENT28 in 1 BOTTLECAPSULE2850

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0069-0980-38EA - Each0069-09802b1ac65d-8177-4d79-93c1-a171464ccceb12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SUNITINIB MALATEACTIVE INGREDIENTLVX8N1UT73SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
SUNITINIBACTIVE MOIETYV99T50803MSUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G675SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRTSUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
GELATININACTIVE INGREDIENT2G86QN327LSUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
MANNITOLINACTIVE INGREDIENT3OWL53L36ASUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
POTASSIUM HYDROXIDEINACTIVE INGREDIENTWZH3C48M4TSUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
POVIDONE K25INACTIVE INGREDIENTK0KQV10C35SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
POVIDONESINACTIVE INGREDIENTFZ989GH94ESUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
SHELLACINACTIVE INGREDIENT46N107B71OSUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32ISUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPSUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]31

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0069-0980SUTENT (SUNITINIB MALATE) CAPSULE [PFIZER LABORATORIES DIV PFIZER INC]48Current NDC, Legacy NDC, 1 package rows20250402_43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
616279SUNItinib malate 12.5 MG Oral CapsulePSN43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616285SUNItinib malate 25 MG Oral CapsulePSN43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
1541890SUNItinib malate 37.5 MG Oral CapsulePSN43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616289SUNItinib malate 50 MG Oral CapsulePSN43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616283Sutent 12.5 MG Oral CapsulePSN43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616287Sutent 25 MG Oral CapsulePSN43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
1541928Sutent 37.5 MG Oral CapsulePSN43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616292Sutent 50 MG Oral CapsulePSN43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616283sunitinib 12.5 MG Oral Capsule [Sutent]SBD43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616287sunitinib 25 MG Oral Capsule [Sutent]SBD43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
1541928sunitinib 37.5 MG Oral Capsule [Sutent]SBD43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616292sunitinib 50 MG Oral Capsule [Sutent]SBD43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616279sunitinib 12.5 MG Oral CapsuleSCD43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616285sunitinib 25 MG Oral CapsuleSCD43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
1541890sunitinib 37.5 MG Oral CapsuleSCD43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616289sunitinib 50 MG Oral CapsuleSCD43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616285sunitinib (as sunitinib malate) 25 MG Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
1541890sunitinib (as sunitinib malate) 37.5 MG Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616279sunitinib 12.5 MG (as sunitinib malate 16.7 MG) Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616289sunitinib 50 MG (as sunitinib malate 66.8 MG) Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616287Sutent (as sunitinib malate) 25 MG Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616283Sutent 12.5 MG (as sunitinib malate 16.7 MG) Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616283Sutent 12.5 MG Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616287Sutent 25 MG Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
1541928Sutent 37.5 MG Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616292Sutent 50 MG (as sunitinib malate 66.8 MG) Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50
616292Sutent 50 MG Oral CapsuleSY43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c50

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0069-0980-380006909803828 CAPSULE in 1 BOTTLE (0069-0980-38) 28 capsule2006-01-260000-00-00NoNoCurrent